Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oxytocin inhaled - GlaxoSmithKline/Monash Institute of Pharmaceutical Sciences

Next Previous
Search
Drug Profile

Oxytocin inhaled - GlaxoSmithKline/Monash Institute of Pharmaceutical Sciences

Alternative Names: GR-121619; Heat-stable oxytocin - GlaxoSmithKline/Monash Institute of Pharmaceutical Sciences

Latest Information Update: 04 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Monash Institute of Pharmaceutical Sciences
  • Developer GlaxoSmithKline
  • Class Amides; Amines; Analgesics; Antihaemorrhagics; Antihyperglycaemics; Antimigraines; Behavioural disorder therapies; Hormones; Macrocyclic lactams; Obesity therapies; Oxytocics; Pyrrolidines
  • Mechanism of Action Oxytocin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Postpartum haemorrhage

Most Recent Events

  • 21 Mar 2021 Janssen Pharmaceuticals and Monash Institute of Pharmaceutical Sciences enter a sponsored research agreement for development of inhaled oxytocin
  • 29 Apr 2020 GlaxoSmithKline returns inhaled oxytocin rights to Monash University (GlaxoSmithKline pipeline, April 2020)
  • 29 Apr 2020 Discontinued - Phase-II for Haemorrhage in United Kingdom (Inhalation) (GlaxoSmithKline pipeline, April 2020)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top